Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-17

Clinical Trial Update: L-Carnitine in Peritoneal Dialysis [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating L-Carnitine in patients with end-stage renal disease on peritoneal dialysis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)

Snippet

Sponsor: Iperboreal Pharma Srl | Conditions: End-Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-06-17